DVAX

Dynavax Technologies Corporation (DVAX)

US
$ 13.79-4.17%

Price Chart

Key Statistics

Market Cap
$ 1.16B
P/E Ratio
0.00
Revenue (TTM)
$ 294.62M
Volume
3.45M
52W High
$ 14.63
52W Low
$ 9.22
Dividend Yield
0.00%
Beta
1.26

Technicals

50-Day MA
12.0478
200-Day MA
12.0415
52 Week High
14.63
52 Week Low
9.22

About DVAX

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV.

Employees
405
Headquarters
EmeryVille, CA
CEO
Mr. Ryan Spencer

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg